Asiaticoside enhances the antitumor efficacy of MSLN-targeted CAR-T cells in ovarian cancer
Abstract Background Chimeric antigen receptor (CAR)-T cell therapy faces significant challenges in treating solid tumors, primarily due to the immunosuppressive tumor microenvironment (TME) and rapid T-cell exhaustion mediated by cytokines such as transforming growth factor-β (TGF-β). Developing str...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2026-03-01
|
| Ráidu: | Journal of Translational Medicine |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1186/s12967-026-08053-w |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
